Weekly CEO Buys Highlight: UTHR, TAT, PMC, BRCD, ENDP

By
A A A

According to GuruFocus Insider Data , these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below:



Utd Therapeutic ( UTHR ): CEO Martine A Rothblatt Bought 31,368 Shares

CEO of Utd Therapeutic ( UTHR ) Martine A Rothblatt bought 31,368 shares during the past week at an average price of $47.78. UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. Utd Therapeutic has a market cap of $2.32 billion; its shares were traded at around $47.78 with a P/E ratio of 9.8 and P/S ratio of 3.1.

Total revenues for the quarter ended March 31, 2012 were $204.2 million, up from $162.5 million for the quarter ended March 31, 2011. Net income for the quarter ended March 31, 2012 was $70.8 million or $1.32 per basic share, compared to $16.4 million or $0.28 per basic share for the same quarter in 2011. Gross margin from sales was $178.9 million for the quarter ended March 31, 2012, compared to $142.5 million for the same quarter last year. Earnings before non-cash charges(1) for the quarter ended March 31, 2012 were $114.4 million, compared to $80.7 million for the quarter ended March 31, 2011.

Richard Perry bought 15,300 shares in the quarter that ended on 03/31/2012, which is 0.035% of the $2.08 billion portfolio of Perry Capital. Joel Greenblatt owns 165,063 shares as of 03/31/2012, an increase of 82.68% from the previous quarter. This position accounts for 0.68% of the $1.15 billion portfolio of Gotham Capital. Edward Owens owns 1,787,000 shares as of 03/31/2012, which accounts for 0.4% of the $20.91 billion portfolio of Vanguard Health Care Fund.

Director Christopher Patusky sold 2,500 shares of UTHR stock on 04/04/2012 at the average price of 45.55. Christopher Patusky owns at least 1,300 shares after this. The price of the stock has increased by 4.9% since. Other insiders have also decreased their positions in the company.

Transatl Petrol ( TAT ): CEO, 10% Owner Noah Malone Mitchell Iii Bought 456,394 Shares

CEO, 10% Owner of Transatl Petrol ( TAT ) Noah Malone Mitchell Iii bought 456,394 shares during the past week at an average price of $0.99. TransAtlantic Petroleum Ltd. is a vertically integrated, international oil and gas company. Transatl Petrol has a market cap of $358.8 million; its shares were traded at around $0.99 with and P/S ratio of 2.8.

Transatlantic Petrol recently reported its second quarter 2012 results. The company reported revenues of $1.2 billion, compared with $1.1 billion for the second quarter of 2011. Net loss was $13.2 million, compared with $8.7 million in 2011.

COO Mustafa Yavuz bought 7,409 shares of TAT stock on 06/12/2012 at the average price of 1. Mustafa Yavuz owns at least 7,409 shares after this.

Pharmerica Corp ( PMC ): CEO Gregory S Weishar Bought 35,500 Shares

CEO of Pharmerica Corp ( PMC ) Gregory S Weishar bought 35,500 shares on 06/14/2012 at an average price of $10.18. PharMerica Corporation is an institutional pharmacy services provider dedicated to providing quality customer service and innovative pharmacy solutions to institutional customers and patients in long-term care settings. Pharmerica Corp has a market cap of $287.9 million; its shares were traded at around $10.18 with a P/E ratio of 7.3 and P/S ratio of 0.1. Pharmerica Corp had an annual average earnings growth of 18.6% over the past 5 years.

Phamerica recently reported its first quarter 2012 financial results. Revenues were $498.9 million, compared to $535.1 million in the first quarter of 2011. Gross profit for the first quarter 2012 was $72.6 million, compared to $66.1 million in the first quarter of 2011.

HOTCHKIS & WILEY owns 768,800 shares as of 03/31/2012, which accounts for 0.057% of the $16.79 billion portfolio of Hotchkis & Wiley Capital Management LLC. Jean-Marie Eveillard sold out his holdings in the quarter that ended on 03/31/2012.

EVP and CFO Michael J Culotta bought 15,000 shares of PMC stock on 06/14/2012 at the average price of 9.51. Michael J Culotta owns at least 158,208 shares after this. The price of the stock has increased by 7.05% since. Other insiders have also increased their positions in the company.

Brocade Comm Sy ( BRCD ): CEO Michael Klayko Bought 60,000 Shares

CEO of Brocade Comm Sy ( BRCD ) Michael Klayko bought 60,000 shares on 06/13/2012 at an average price of $4.79. Brocade Communications Systems, Inc. delivers industry-platforms, solutions, and services for intelligently connecting, managing, and optimizing IT resources in shared storage environments. Brocade Comm Sy has a market cap of $2.14 billion; its shares were traded at around $4.79 with a P/E ratio of 12.6 and P/S ratio of 1. Brocade Comm Sy had an annual average earnings growth of 15.3% over the past 10 years. GuruFocus rated Brocade Comm Sy the business predictability rank of 2-star.

BRCD recently reported financial results for its second fiscal quarter ended April 28, 2012. Brocade reported second quarter revenue of $543.4 million, representing a decrease of 1% year-over-year and 3% quarter-over-quarter and resulting in diluted earnings per share of $0.08 on a GAAP basis and diluted earnings per share of $0.15 on a non-GAAP basis, up 58% and 24% year-over-year, respectively.

David Dreman bought 4,141,969 shares in the quarter that ended on 03/31/2012, which is 0.5% of the $4.79 billion portfolio of Dreman Value Management. Ray Dalio owns 543,135 shares as of 03/31/2012, an increase of 1579.71% from the previous quarter. This position accounts for 0.049% of the $6.43 billion portfolio of Bridgewater Associates. Joel Greenblatt owns 243,087 shares as of 03/31/2012, an increase of 123.38% from the previous quarter. This position accounts for 0.12% of the $1.15 billion portfolio of Gotham Capital.

CFO, VP of Finance Daniel W Fairfax sold 20,378 shares of BRCD stock on 03/23/2012 at the average price of 5.65. Daniel W Fairfax owns at least 218,123 shares after this. The price of the stock has decreased by 15.22% since. Other insiders have also decreased their positions in the company.

Endo Pharmaceut ( ENDP ): President & CEO David Holveck Bought 8,550 Shares

President & CEO of Endo Pharmaceut ( ENDP ) David Holveck bought 8,550 shares on 06/12/2012 at an average price of $30.13. Endo Pharmaceuticals Holdings Inc., through its wholly owned subsidiaries, Endo Pharmaceuticals Inc. Endo Pharmaceut has a market cap of $3.5 billion; its shares were traded at around $30.13 with a P/E ratio of 6.5 and P/S ratio of 1.3. Endo Pharmaceut had an annual average earnings growth of 31.7% over the past 10 years. GuruFocus rated Endo Pharmaceut the business predictability rank of 3.5-star.

Joel Greenblatt bought 17,025 shares in the quarter that ended on 03/31/2012, which is 0.057% of the $1.15 billion portfolio of Gotham Capital. Lee Ainslie owns 5,508,833 shares as of 03/31/2012, an increase of 86.23% from the previous quarter. This position accounts for 3.1% of the $6.95 billion portfolio of Maverick Capital. David Dreman owns 92,625 shares as of 03/31/2012, which accounts for 0.075% of the $4.79 billion portfolio of Dreman Value Management. John Hussman owns 1,914,000 shares as of 03/31/2012, which accounts for 1.4% of the $5.16 billion portfolio of Hussman Economtrics Advisors.About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing

Referenced Stocks: BRCD , ENDP , PMC , TAT , UTHR

GuruFocus

GuruFocus

More from GuruFocus:

Related Videos

Stocks

Referenced

Most Active by Volume

9,234,476
  • $14.775 ▼ 2.22%
4,949,177
  • $13.9667 ▼ 4.99%
4,650,242
  • $56.2173 ▲ 6.76%
3,852,629
  • $17.06 ▲ 0.29%
3,216,336
  • $101.27 ▲ 1.16%
2,198,158
  • $95.45 ▲ 4.96%
2,195,776
  • $98.82 ▲ 0.17%
2,185,662
  • $46.16 ▼ 0.60%
As of 9/30/2014, 09:36 AM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com